Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

History of the share capital

The table below provides an overview of the history of the company’s share capital since its incorporation on May 30, 2006.

Date Transaction

Number of

shares issued

Issue price

per share (€)

Capital

Increase (€)

Issue Premium

paid (€)

Share capital

after

transaction (€)

Aggregate number

of shares

after transaction  

  May 30th 2006 Incorporation 11.124 5,57 - - 62.000,00 11.124
  Jul 5th 2006 Contribution
in kind
14.351.403 4.50 64.581.313,50 - 64.643.313,50 14.362.527
  Jul 7th 2006 Capital increase in cash 7.777.778 4.50 35.000.001,00 - 99.643.314,50 22.140.305
  May 9th 2007 Capital increase in cash 2.214.030 4.50 9.964.329,20 13.947.194,80 109.607.643,70 24.354.335
  Sep 13th 2007 Exercise of warrants 1.147.825 4.50 5.165.212,50 1.699.937,50 114.772.856,20 25.502.160
  Apr 8th 2008 Exercise of warrants 172.629 4,50 776.919,43 86.225,57 115.549.775,63 25.674.789
  Oct 10th 2008 Exercise of warrants 56.000 4,50 252.028,85 103.171,15 115.801.804,48 25.730.789
  Apr 9th 2009 Exercise of warrants 38.000 4,50 171.019,58 70.580,42 115.972.804,48 25.768.789
  Apr 30th 2009 Exercise of warrants 559.000 4,45 2.487.550,00 - 118.460.374,06 26.327.789
  Oct 5th 2009 Exercise of warrants 90.000 4,50 404.949,83 231.420,17 118.865.323,89 26.417.789
  Nov 20th 2009 Capital increase in cash 2.641.778 4,50 11.886.528,34 30.381.919,66 130.751.852,23 29.059.567
  Mar 22nd 2010 Exercise of warrants 96.667 4,50 434.947,62 139.431,93 131.186.799,85 29.156.234
  Oct 22nd 2010 Exercise of warrants 289.000 4,50 1.300.338,90 1.544.511,10 132.487.138,75 29.445,234
  Dec 8th, 2010 Capital increase in cash 2.944.523 4,50 13.248.712,08 42.697.224,92 145.735.850,83 32.389,757
  Mar 25th 2011 Exercise of warrants 24.000 4,50 107.986,63 65.353,37 145.843.837,46 32.413,757
  Oct 28th 2011 Exercise of warrants 33.000 4,50 148.481,61 198.088,39 145.992.319,07 32.446.757
  Apr 3rd, 2012 Capital increase in cash 3.244.675 4,50 14.599.228,76 63.272.971.24 160.591.547,83 35.691.432
  May 21st, 2012 Exercise of warrants 121.917 4,50 548.558,54 834.573,51 161.140.106,37 35.813.349
  Oct 17th, 2012 Exercise of warrants 46.875 4,50 210.911,37 481.096,13 161.351.017,74 35.860.224
  Apr 25th, 2013 Exercise of warrants 234.125 4,50 1.053.431,99 1.907.560,51 162.404.449,73 36.094.349
  Jan 5th, 2018 Capital increase in cash 2,177,226 4,50 9.796.303,31 203.696,69 172.200.753,04 38.271.575
  Jun 1st, 2018 Capital decrease - - -24.302.544,14 -157.864.957,06 147.898.208,90   38.271.575
  Nov 8th, 2018            Exercise of warrants 20.375 3,86   78.737,97  12.949,53 147.976.946,87    38.291.950
Dec 13th and 30th, 2019 Capital decrease - - -36.920.014,87 -12.949,53 111.056.932,00 38.291.950
Aug 6th and Aug 24th, 2020 Capital decrease - - -50.198.374,38 - 60.858.557,62 38.291.950
Aug 6th and Aug 24th, 2020 Capital decrease - - -5.532.596,62 - 55.325.961,00 38.291.950
Sep 29th, 2021 Conversion of convertible bonds 152.439 1,64 219.512,16 30.487,84 55.545.473,16 38.444.389
Oct 7th, 2021 Conversion of convertible bonds 156.250 1,60 225.000,00 25.000,00 55.770.473,16 38.600.639
Nov 10th, 2021 Conversion of convertible bonds 263.157 1,90 378.946,08 121.053,92 56.149.419,24 38.863.796
Dec 23rd, 2021 Conversion of convertible bonds 203.488 1,72 293.022,72 56.977,28 56.442.441,96 39.067.284
Feb 8th, 2022 Conversion of convertible bonds 335.569 1,49 483.219,36 16.780,64 56.925.661,32 39.402.853
Mar 7th, 2022 Capital increase in cash 7.226.039 1,44 10.405.500,00 - 67.331.161,32 46.628.892
Mar 23rd, 2022 Conversion of convertible bonds 500.000 1,20 600.000,00 - 67.931.161,32 47.128.892